Unchanged viability in ovarian cancer cells
Cell-based study · A2780 ovarian cancer cells [1]
A2780 ovarian cancer cells were incubated with Pravastatin at 0.1–1-10 uM for 48 hrs. No reduction in cell viability was observed by MTS assays.
| Endpoint | Reported result | Reference |
|---|---|---|
| Cell viability was measured by MTS assays. | Reported result 0.1–1-10 uM, 48 hrs: No reduction in cell viability was observed with pravastatin. | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- 0.1–1-10 uM
- Exposure duration
- 48 hrs
- Method
- incubated
- Vehicle
- distillated water
Methods and source locations
Compound reported in the paper: Pravastatin
The paper names Pravastatin without stating the salt or form; not verified as the sodium form supplied as A11912. No dose conversion or lot validation.
Materials and methods > Reagents (S2); Results > Lipophilic (lovastatin and simvastatin) but not hydrophilic (pravastatin) statins mediate apoptosis in ovarian cancer cell lines (S64, S66); Fig 1 legend (S118, S119, S121)
Cell viability was measured by MTS assays.: Cell viability was measured by MTS assays.; comparator: vehicle (DMSO) — Results > Lipophilic (lovastatin and simvastatin) but not hydrophilic (pravastatin) statins mediate apoptosis in ovarian cancer cell lines (S64, S66); Fig 1 legend (S119)